Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Forschungsprojekte
Ergebnisse pro Seite:
100
2020 - 2025
Concordance of PD-L1 expression in breast carcinoma between primarius and metastasis- Univ.-Prof. Dr. MarcusSchmidt,
- Dr. KathrinStewen
2018 - 2025
AGO Ovar 22: A Phase III, multicenter, randomized, study of Atezolizumab versus placebo administered in combination with Paclitaxel, Carboplatin and Bevacizumab to patients with newly diagnosed Stage III or Stage IV ovarian, Fallopian Tube or primary Peritoneal Cancer- Univ.-Prof. Dr. AnnetteHasenburg,
- Dr. MarcoBattista
2018
AGO Ovar 2.29 Atezolizumab in Kombination mit Bevacizumab und Chemotherapie versus Bevacizumab und Chemotherapie beim rezidivierenden Ovarialkarzinom - eine randomisierte Phase III Studie- Dr. KatrinAlmstedt,
- Univ.-Prof. Dr. AnnetteHasenburg
2017 - 2019
Histone deacetylase 6 as a new target in the therapy of ovarian cancer- Dr. InesBreuksch,
- Prof. Dr. WalburgisBrenner,
- Univ.-Prof. Dr. OliverKrämer
2017 - 2020
Impact of the Calcium sensing receptor on the progression of ovarian cancer and endometriosis- Prof. Dr. WalburgisBrenner
2017 - 2020
Impact of the tissue factor in the integration of a pre-vascularized in vitro mucosa equivalent- Dr. SandraNezi,
- Dr. MartinHeller,
- Prof. Dr. WalburgisBrenner
2017 - 2020
Mütterliche Präferenzen bei der Entscheidungsfindung für Frühgeborene im Grenzbereich der Lebensfähigkeit (PREFAB-Studie)- Dr. AndréKidszun,
- Univ.-Prof. Dr. EvaMildenberger
2017 - 2020
MUC1 variant as a potential target in the therapy of triple-negative breast cancer (TNBC)- Dr. Anne-SophieHeimes
2016 - 2020
Identification and characterization of exosomal miRNA‘s in liquid biopsies as marker in breast cancer- Dr. RoxanaSchwab,
- Prof. Dr. WalburgisBrenner
2016 - 2020
Analysis of antibody responses against tumor-derived neo-antigens in triple-negative breast cancer (TNBC)- Dr. Anne-SophieHeimes,
- Univ.-Prof. Dr. MarcusSchmidt,
- Prof. Dr. WalburgisBrenner
2016 - 2025
DESIREE – eine multizentrische, randomisierte doppelblinde, Phase-II-Studie zum Vergleiche der Verträglichkeit bei- Univ.-Prof. Dr. MarcusSchmidt,
- Dr. MarcoBattista
2015 - 2018
Identifizierung diagnostischer Marker zur verbesserten Therapieentscheidung beim nodal-negativen Mammakarziniom- Univ.-Prof. Dr. MarcusSchmidt,
- Univ.-Prof. Dr. WilfriedRoth,
- Univ.-Prof. Dr. UgurSahin
2015 - 2020
Development and characterization of an in vitro generated pre-vascularized mucosa equivalent- Prof. Dr. WalburgisBrenner
2015 - 2020
Role of the tumor suppressor PTEN and its splice variant PTENdelta in tumorigenesis and metastasis- Prof. Dr. WalburgisBrenner
2014 - 2016
Prozessoptimierung zur Identifikation von patienten-spezifischen Antigen-Expressionsprofilen und individuellen Tumormutationen bei Brustkrebspatientinnen- Univ.-Prof. Dr. MarcusSchmidt,
- Univ.-Prof. Dr. UgurSahin
2014 - 2018
Energy metabolism in ovarian cancer- Dr. Marco JohannesBattista,
- PD Dr. StefanWalenta,
- Univ.-Prof. Dr. WolfgangMüller-Klieser,
- Univ.-Prof. Dr. MarcusSchmidt,
- Univ.-Prof. Dr. AnnetteHasenburg
2014 - 2016
Isolation und Charakterisierung von Tumorstammzellen aus Pleura-/Aszitespunktaten- Univ.-Prof. Dr. MarcusSchmidt,
- PD Dr. Marcus-AlexanderWörns,
- Univ.-Prof. Dr. UgurSahin
2013 - 2016
PASSOS: Personalized estimation of long-term outcomes after radiation exposure and orientations help for radiation help in medicine (BMBF)- Univ.-Prof. Dr. MariaBlettner,
- PD Dr. MarkusSchmidt,
- Univ.-Prof. Dr. HeinzSchmidberger
2012 - 2025
Identification of prognostic and predictive factors in breast cancer using Next-Generation Sequencing (NGS)- PD Dr. MarcusSchmidt,
- Univ.-Prof. Dr. UgurSahin,
- Dr. CastleJohn
2011 - 2013
Geburtsmodus Frühgeborener eines Schätzgewichtes < 1500g- Univ.-Prof. Dr. EvaMildenberger,
- Anne-JuleFuchs
2011 - 2012
Anti Müllersches Hormon und Verlust von Ovargewebe bei endoskopisch-gynäkologischen Eingriffen- Dr. ChristineSkala,
- Dr. RuthGomez,
- Dr. MartinSchorsch,
- Dr. JuliaZelasny,
- Univ.-Prof. Dr. RudolfSeufert
2011 - 2025
Characterization of the immunoglobulin repertoire of tumor-infiltrating plasma cells and correlation of factors within the plasma with prognosis in early breast cancer- Univ.-Prof. Dr. MarcusSchmidt
2010 - 2012
Regulation der AMH-Rezeptoren in vitro am Modell der Granulosazellkulturen (MAIFOR-Projekt)- Dr. VerenaPassuello
2010 - 2025
Characterization of lymphocytic infiltrates as prognostic and predictive markers in breast cancer- Univ.-Prof. Dr. MarcusSchmidt
2010 - 2011
A Dose-Escalating Phase I Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PDC31 in Patients with Primary Dysmenorrhea- Univ.-Prof. Dr. RudolfSeufert,
- Dr. RosaLaterza,
- Univ.-Prof. Dr. Dr. h.c. HeinzKoelbl
2010 - 2011
"A prospective single arm study to determine the most predictable assessment tool in relation to outcome for women treated with Solifenacin for OAB symptoms arising ex novo or worsening after positioning of sling procedure for stress urinary incontinence"- Univ.-Prof. Dr. Dr. h.c. HeinzKoelbl,
- Dr. RosaLaterza
2010 - 2011
Pelvic floor dysfunction after levator trauma 1 year after vaginal delivery: a prospective case-control study- Dr. Rosa MariaLaterza,
- Dr. LoreSchrutka,
- Dr. StefanAlbrich,
- Dr. GertNaumann,
- Univ.-Prof. Dr. Dr. h.c. HeinzKoelbl
2010 - 2013
Reprodoc - Dokumentations- und Informationssystem für die Reproduktionsmedizin mit Verbindung zur KI- Univ.-Prof. Dr. RudolfSeufert,
- Dr. StefanQuerbach,
- Dr. RuthGomez,
- Dr. ChristineSkala
2010 - 2014
Zertifizierung und praktische Verbesserung des QM - Systems nach ISO 9001: 2008 in der Reproduktionsmedizin- Univ.-Prof. Dr. RudolfSeufert,
- Dr. ChristineSkala,
- Dr. RuthGomez,
- BartoczLinek,
- Dr. IlkaPetry
2010 - 2013
Prognosefaktoren der intrauterinen Insemination- Dr. RuthGomez,
- Dr. ChristineSkala,
- Dr. MartinSchorsch,
- Univ.-Prof. Dr. RudolfSeufert
2010 - 2011
Evaluation des Hormonmessautomaten Pathfast- Univ.-Prof. Dr. RudolfSeufert,
- PD Dr. CPeetz